tradingkey.logo
tradingkey.logo
Search

Champions Oncology Inc

CSBR
Add to Watchlist
5.960USD
-0.085-1.41%
Close 07/02, 13:00ETQuotes delayed by 15 min
82.77MMarket Cap
LossP/E TTM

More Details of Champions Oncology Inc Company

Champions Oncology, Inc. is a preclinical and clinical research services provider. The Company is engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs through its translational oncology solutions. This technology ranges from computational-based discovery platforms, oncology software solutions, and proprietary experimental tools such as in vivo, ex vivo and biomarker platforms. Utilizing its TumorGraft Technology Platform (the Platform), it provides select services to pharmaceutical and biotechnology companies seeking personalized approaches to drug development. It also sells Lumin Bioinformatics (Lumin), an oncology data-driven software program which contains comprehensive information derived from its research services and clinical studies. Lumin leverages a large data center coupled with analytics and artificial intelligence to provide a robust tool for computational cancer research.

Champions Oncology Inc Info

Ticker SymbolCSBR
Company nameChampions Oncology Inc
IPO dateNov 30, 1988
CEOBrainin (Robert)
Number of employees213
Security typeOrdinary Share
Fiscal year-endNov 30
AddressOne University Plaza,
CityHACKENSACK
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code07601
Phone12018088400
Websitehttps://championsoncology.com
Ticker SymbolCSBR
IPO dateNov 30, 1988
CEOBrainin (Robert)

Company Executives of Champions Oncology Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Joel Ackerman
Mr. Joel Ackerman
Independent Director
Independent Director
1.06M
+8.94%
Dr. Ronnie Morris, M.D.
Dr. Ronnie Morris, M.D.
Chairman of the Board
Chairman of the Board
858.88K
--
Dr. David Sidransky, M.D.
Dr. David Sidransky, M.D.
Independent Director
Independent Director
767.04K
--
Mr. Scott R. Tobin
Mr. Scott R. Tobin
Independent Director
Independent Director
53.40K
+43.82%
Mr. Daniel N. (Dan) Mendelson
Mr. Daniel N. (Dan) Mendelson
Independent Director
Independent Director
--
--
Mr. David Miller, CPA
Mr. David Miller, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Philip Breitfeld, M.D.
Dr. Philip Breitfeld, M.D.
Independent Director
Independent Director
--
--
Mr. Robert (Rob) Brainin
Mr. Robert (Rob) Brainin
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Joel Ackerman
Mr. Joel Ackerman
Independent Director
Independent Director
1.06M
+8.94%
Dr. Ronnie Morris, M.D.
Dr. Ronnie Morris, M.D.
Chairman of the Board
Chairman of the Board
858.88K
--
Dr. David Sidransky, M.D.
Dr. David Sidransky, M.D.
Independent Director
Independent Director
767.04K
--
Mr. Scott R. Tobin
Mr. Scott R. Tobin
Independent Director
Independent Director
53.40K
+43.82%
Mr. Daniel N. (Dan) Mendelson
Mr. Daniel N. (Dan) Mendelson
Independent Director
Independent Director
--
--
Mr. David Miller, CPA
Mr. David Miller, CPA
Chief Financial Officer
Chief Financial Officer
--
--

FAQs

Who are the top five shareholders of Champions Oncology Inc?

The top five shareholders of Champions Oncology Inc are: Mr. Joel Ackerman

How many institutions hold shares of Champions Oncology Inc (CSBR)?

As of 2026Q1, 61 institutions hold shares of Champions Oncology Inc, with a combined market value of approximately 6.66M, accounting for 47.97% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -413745.00.